PAGS Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unavailable AEVA Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amid PreRevenue Stage SIRI Q1 2026 Earnings EPS Surpasses Estimates Yet Stock Declines INCY Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline YALA Q1 2026 Earnings EPS of 016 Reported Stock Rises Amid Limited Disclosures Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances